EUVIMEDEUVIMED entdecken
Crossref

Rhabdomyolysis and statins: A pharmacovigilance comparative study between statins

Jean-Louis Montastruc iD

British Journal of Clinical Pharmacology · 2023-08 · 89 (8) · 2636-2638

DOI: 10.1111/bcp.15757 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, online erschienen am 08.05.2023. Verfasst von Jean-Louis Montastruc. Beteiligte Einrichtung: Medical and Clinical Pharmacology, Toulouse, France. Hauptthemen laut MEDLINE: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Rhabdomyolysis. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rhabdomyolysis is a serious adverse drug reaction of statins. There are few studies comparing the risk of rhabdomyolysis between the different statins. Using the WHO pharmacovigilance database, VigiBase®, we compared the risk of rhabdomyolysis reporting of seven statins (atorvastatin, fluvastatin, lovastatin, pitavastatin, pravastatin, rosuvastatin and simvastatin, with cerivastatin excluded). All reports of rhabdomyolysis in VigiBase® in adults with statins until 31 December 2022 were included. Results are expressed as reporting odds ratio (ROR, 95% CI). Among 10 657 reports with rhabdomyolysis with statins, simvastatin was the highest risk statin in comparison with others: ROR = 2.20 (2.11–2.29). The risk was higher in men, older than 74 years and in cases of drug interactions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hydroxymethylglutaryl-CoA Reductase InhibitorsRhabdomyolysisMaleAdultHumansPharmacovigilanceSimvastatinAtorvastatin

Stichwörter der Autor:innen

adverse drug reactionspharmacovigilancestatins

Substanzen

Hydroxymethylglutaryl-CoA Reductase InhibitorsSimvastatinAtorvastatin

Autor:innen und Institutionen

  • Medical and Clinical Pharmacology, Toulouse, France.

ORCID-Profile: Jean-Louis Montastruc

Zitieren

APA

Montastruc, J. L. (2023). Rhabdomyolysis and statins: A pharmacovigilance comparative study between statins. British Journal of Clinical Pharmacology, 89(8), 2636-2638. https://doi.org/10.1111/bcp.15757

Vancouver

Montastruc JL. Rhabdomyolysis and statins: A pharmacovigilance comparative study between statins. British Journal of Clinical Pharmacology. 2023;89(8):2636-2638. doi:10.1111/bcp.15757

BibTeX
@article{Montastruc2023,
  author = {Montastruc, Jean-Louis},
  title = {Rhabdomyolysis and statins: A pharmacovigilance comparative study between statins},
  journal = {British Journal of Clinical Pharmacology},
  year = {2023},
  volume = {89},
  number = {8},
  pages = {2636--2638},
  doi = {10.1111/bcp.15757}
}
Kostenlos starten →